Inclusion Criteria:

   - Patient with a planned admission for at least 24 hours for highly emetogenic or
   moderately emetogenic chemotherapy at Lucile Packard Children's Hospital or Packard El
   Camino.

   - Planned to undergo at least 2 more cycles of chemotherapy.

   - Can include but not limited to: children with high risk ALL, AML, Ewing's Sarcoma,
   Osteosarcoma

   - History of vomiting with prior cycles of chemotherapy (2 episodes of emesis at
   minimum) despite use of conventional antiemetic medications.

   - Age 8-21.

   - Parent must be able to understand and willing to sign written informed consent
   document.

Exclusion Criteria:

   - Prior knowledge of acupuncture or experience with acupuncture or acupressure.

   - There will be no restrictions regarding use of other Investigational Agents.

   - Comorbid Diseases:

      - Diagnosis of any cardiac condition (cardiomyopathy, arrhythmia, pacemaker
      placement).

      - Any diagnosis requiring pediatric intensive care unit admission.

      - Patients with brain tumor, brain metastasis (these patients often require
      radiation and surgery in addition to chemotherapy which may confound the results)

      - Concomitant radiation therapy during current chemotherapy cycle.

      - Developmental delay patients with allergy to tape or leads will be excluded from
      the study.

   - Pregnant patients will be excluded from the study.

   - Cancer survivors will not be excluded from the study as long as they are undergoing
   chemotherapy treatment for their current cancer therapy.

   - HIV-positive patients will not be excluded.